Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Why a Pfizer Takeover of Bristol-Myers Squibb Seems Unlikely
- Deutsche Bank analyst Barbara Ryan left pharma pholks with an interesting wishbone to chew on prior to Thanksgiving -- the notion that large pharma was overdue for consolidation and that Pfizer ought to consider finally merging with Bristol-Myers Squibb. It's not a new idea, of course. But is a Pfizer...
- Blog posts 2008-11-29
- Reaction to Pfizer-Wyeth: Employees Despair, Plot Rebellion; Analysts Shrug; PFE Stock Down 10%
- Reaction to the Pfizer-Wyeth merger is ... mixed, to say the least. Pfizer employees think this will be Pharmacia/Warner-Lambert redux. Wall Street analysts are all over the place. Pfizer's stock has lost 10 percent of its value between the opening bell and lunchtime. Wyeth's...
- Blog posts 2009-01-26
Additional Resources
- Pfizer's Kindler Got $4.2 Million Pay Raise, Despite What Business Press Says
- To hear the business press tell it, Pfizer CEO Jeff Kindler took a pay cut in 2008. That's not what Pfizer's proxy statement, filed this morning, says. Kindler's total compensation rose from $9.5 million to $13.7 million in 2008. His basic salary rose from $1.4 million to...
- Blog posts 2009-03-13
- PFIZER INC - Pfizer Board Of Directors Names Jeffrey B. Kindler CEO.
- Pfizer Board of Directors Names Jeffrey B. Kindler Chief Executive Officer Kindler Succeeds Hank McKinnell, Who Will Remain Chairman of the Board Until ...
- Research articles 2006-07-31
- Rayonier Names Kindler Vice President, Specialty Pulp
- STAMFORD, Conn.--BUSINESS WIRE--Sept. 5, 1996--William A. Kindler, 53, has joined Rayonier as Vice President, Specialty Pulp, reporting to W. Lee Nutter, President and Chief Operating Officer. In this new position Kindler has overall responsibility for the Specialty Pulp business, which includes manufacturing, marketing, research and development and engineering.Kindler joins Rayonier...
- Research articles 1996-09-05
- Billion dollar pills - Pharmaceuticals.(views of Jeffrey Kindler of Pfizer Inc. on pharmaceutical industry)
- Kindler sets out his plan Kindler sets out his plan
- Research articles 2007-01-27
- People: Kindler to apply legal skills to McD's diversification push.(Brief Article)(Statistical Data Included)
- McDonald's Corp. has tapped a lawyer to lead its diversification into the world beyond Big Macs and fries. Jeffrey B. Kindler, the company's 44-year-old general counsel and executive vice-president, recently was named liaison to the ailing Boston McDonald's Corp. has tapped a...
- Research articles 2000-01-17
- Pfizer's Kindler Joins BIO Board of Directors
- WASHINGTON -- The Biotechnology Industry Organization BIO today announced the election of Pfizer Chairman and CEO Jeffrey B. Kindler to BIO's Board of Directors. Kindler will replace Pfizer Vice President of Corporate Policy and Strategic Management Fred Telling, who had served on the BIO Board for eleven years and is...
- Research articles 2007-02-20
- Robert A. Kindler Joins Morgan Stanley as Vice Chairman of Investment Banking; Brings Wealth of Experience and Relationships, Having Advised on Transactions Totaling Over $200 Billion
- NEW YORK -- Morgan Stanley (NYSE:MS) announced today that Robert A. Kindler, 52, has joined the Firm as a Vice Chairman of Investment Banking. Mr. Kindler will focus on senior client relationships and coordinate closely with senior management on new business initiatives.
- Research articles 2006-04-06
- Pfizer taps Kindler, Ucelli to fill key corporate posts
- PFIZER HAS CHOSEN vice chairman and general counsel Jeff Kindler to replace Chuck Hardwick as head of global corporate affairs following Hardwick's retirement. The company also has selected Loretta Ucelli, formerly the communications chief for Columbia University, to serve in the new post of senior vice president, corporate communications.
- Research articles 2005-09-01
- Pfizer on Track to Deliver Greater Shareholder Value, CEO Kindler Tells Shareholders
- MEMPHIS, Tenn. -- Today at Pfizer's annual shareholder meeting, Chairman and Chief Executive Officer Jeffrey B. Kindler detailed his plan to build on the Company's foundation to drive greater shareholder return.
- Research articles 2008-04-24
- Pfizer Focused on Delivering the Value Customers Expect and Shareholders Deserve, CEO Kindler Tells Shareholders
- SOUTH BEND, Ind. -- In remarks at the annual shareholders meeting, Pfizer Chairman and Chief Executive Officer Jeffrey B. Kindler said, "We're operating in an incredibly dynamic industry environment - one that, day in and day out, presents us with a whole range of promising opportunities. To succeed in this...
- Research articles 2007-04-26
- Pfizer's Layoff Plan Explained
- Pfizer CEO Jeff Kindler isn't resting in his reorganization of the company. But although that plan is said not to involve layoffs, no one seems to believe it. As such, Pfizer is heading into territory previously ploughed by GlaxoSmithKline, which was plagued by layoff rumors throughout the summer while the...
- Blog posts 2008-10-08
- Pharma Election Money Backs Obama
- After years of funneling campaign money to Republican politicians, the drug business has suddenly decided that the Democrats -- who took control of Congress in the 2006 elections -- will win the White House in the fall. From 1990 until just last year, pharma political campaign contribution...
- Blog posts 2008-08-19
- Pfizer Q1 2009 Earnings Call Transcript
- Question-and-Answer SessionOperator Thank you. Operator Instructions. And our first question comes from Catherine Arnold of Credit Suisse. Please proceed. Catherine Arnold - Credit Suisse Thanks very much. Good morning. Jeffrey Kindler Good morning. Catherine Arnold - Credit Suisse Good Morning. I wanted to ask you two things. One, could...
- Earnings calls 2009-04-28
- Odds May Be Against a Pfizer-Bayer Deal
- The chatter in Europe today is the rumor that Pfizer may be interested in acquiring Bayer. Bayer's stock is trading up on the news. It's an interesting prospect. Pfizer's stock is in the dumpster and won't start looking up until its pipeline starts to revive after 2011....
- Blog posts 2008-09-09
- Pfizer, Inc. Q4 2007 Earnings Call Transcript
- Question-and-Answer SessionTimothy Anderson - Prudential Equity Group, LLC On Lipitor, hoping you can provide us an update on what the unrestricted tier 2 access is in the U.S. for the product in 2008 relative to what it was for 2007. If you could remind us what that figure was...
- Earnings calls 2008-01-23
- Starved of News, Press Speculates on Deals for Abbott, Pfizer and Wyeth
- New Year is a slow news period, which is why the business press filled up with next-to-useless corporate strategy stories about Abbott Labs, Wyeth and Pfizer. The one thing these stories all have in common? They're long on speculation and short on substance. Let's take them one at a time....
- Blog posts 2009-01-05
- Pfizer's Wyeth Buy Eclipses $2.3 Bill. Bextra Troubles; 19,000 Layoffs to Come
- Today's announcement that Pfizer is to acquire Wyeth for $68 million eclipsed some things that on any other day would have been headline news in themselves: a) The fact that Pfizer's earnings were down 90 percent due to a $2.3 billion settlement with the Department of Justice over its off-label...
- Blog posts 2009-01-26
- MANUFACTURERS
- Pfizer has formed a new executive committee, where Karen Katen, Jeff Kindler and David Shedlarz will accompany chief executive Hank McKinnell and hold the title of vice chairman of Pfizer. Meanwhile, Katen has been promoted to president of Pfizer Human Health, from president of Pfizer Global Pharmaceuticals. Kindler, who oversees...
- Research articles 2005-04-01
- << Previous
- page 1 of 1
- Next >>
